Showing 1 of 1 recruiting trials for “T-cell large granular lymphocyte leukemia”
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
👨⚕️ Jonathan Brammer, MD, Ohio State University Comprehensive Cancer Center📍 3 sites📅 Started May 2023View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →